Divergent effects of insulin-like growth factor-1 receptor expression on prognosis of estrogen receptor positive versus triple negative invasive ductal breast carcinoma. (Q51531354)

From Wikidata

Jump to navigation Jump to search

scientific article published on 24 November 2010

Language	Label	Description	Also known as
English	Divergent effects of insulin-like growth factor-1 receptor expression on prognosis of estrogen receptor positive versus triple negative invasive ductal breast carcinoma.	scientific article published on 24 November 2010

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21107683 AND SRC:MED&resulttype=core&format=json

17 January 2020

Divergent effects of insulin-like growth factor-1 receptor expression on prognosis of estrogen receptor positive versus triple negative invasive ductal breast carcinoma (English)

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21107683 AND SRC:MED&resulttype=core&format=json

17 January 2020

1 reference

based on heuristic

inferred from title

Bert van der Vegt

3

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21107683 AND SRC:MED&resulttype=core&format=json

17 January 2020

4

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21107683 AND SRC:MED&resulttype=core&format=json

17 January 2020

Truuske de Bock

8

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21107683 AND SRC:MED&resulttype=core&format=json

17 January 2020

author name string

Hermien Hartog

1

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21107683 AND SRC:MED&resulttype=core&format=json

17 January 2020

Hugo M Horlings

2

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21107683 AND SRC:MED&resulttype=core&format=json

17 January 2020

Abderrahim Ajouaou

5

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21107683 AND SRC:MED&resulttype=core&format=json

17 January 2020

H Marike Boezen

7

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21107683 AND SRC:MED&resulttype=core&format=json

17 January 2020

Winette T A van der Graaf

9

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21107683 AND SRC:MED&resulttype=core&format=json

17 January 2020

Jelle Wesseling

10

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21107683 AND SRC:MED&resulttype=core&format=json

17 January 2020

Marc J van de Vijver

6

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21107683 AND SRC:MED&resulttype=core&format=json

17 January 2020

language of work or name

0 references

publication date

24 November 2010

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21107683 AND SRC:MED&resulttype=core&format=json

17 January 2020

Breast Cancer Research and Treatment

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21107683 AND SRC:MED&resulttype=core&format=json

17 January 2020

129

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21107683 AND SRC:MED&resulttype=core&format=json

17 January 2020

3

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21107683 AND SRC:MED&resulttype=core&format=json

17 January 2020

725-736

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21107683 AND SRC:MED&resulttype=core&format=json

17 January 2020

The insulin-like growth factor 1 receptor in cancer: old focus, new future

1 reference

https://api.crossref.org/works/10.1007/S10549-010-1256-6

21 January 2018

Insulin and insulin-like growth factor signalling in neoplasia

1 reference

https://api.crossref.org/works/10.1007/S10549-010-1256-6

21 January 2018

Combination therapy enhances the inhibition of tumor growth with the fully human anti-type 1 insulin-like growth factor receptor monoclonal antibody CP-751,871.

1 reference

https://api.crossref.org/works/10.1007/S10549-010-1256-6

21 January 2018

What clinicians need to know about antioestrogen resistance in breast cancer therapy

1 reference

https://api.crossref.org/works/10.1007/S10549-010-1256-6

21 January 2018

Insulin-like growth factor-I receptor/human epidermal growth factor receptor 2 heterodimerization contributes to trastuzumab resistance of breast cancer cells

1 reference

https://api.crossref.org/works/10.1007/S10549-010-1256-6

21 January 2018

Receptor tyrosine kinases: mechanisms of activation and signaling

1 reference

https://api.crossref.org/works/10.1007/S10549-010-1256-6

21 January 2018

Insulin and insulin-like growth factor I receptors: similarities and differences in signal transduction.

1 reference

https://api.crossref.org/works/10.1007/S10549-010-1256-6

21 January 2018

The relationship between the insulin-like growth factor-1 system and the oestrogen metabolising enzymes in breast cancer tissue and its adjacent non-cancerous tissue

1 reference

https://api.crossref.org/works/10.1007/S10549-010-1256-6

21 January 2018

In vivo antitumor activity of NVP-AEW541-A novel, potent, and selective inhibitor of the IGF-IR kinase

1 reference

https://api.crossref.org/works/10.1007/S10549-010-1256-6

21 January 2018

In vitro and in vivo antitumor effects of the dual insulin-like growth factor-I/insulin receptor inhibitor, BMS-554417.

1 reference

https://api.crossref.org/works/10.1007/S10549-010-1256-6

21 January 2018

Inhibition of the insulin-like growth factor receptor-1 tyrosine kinase activity as a therapeutic strategy for multiple myeloma, other hematologic malignancies, and solid tumors

1 reference

https://api.crossref.org/works/10.1007/S10549-010-1256-6

21 January 2018

Co-targeting insulin-like growth factor I receptor and HER2: dramatic effects of HER2 inhibitors on nonoverexpressing breast cancer

1 reference

https://api.crossref.org/works/10.1007/S10549-010-1256-6

21 January 2018

Insulin-like growth factor-I receptor signalling and acquired resistance to gefitinib (ZD1839; Iressa) in human breast and prostate cancer cells

1 reference

https://api.crossref.org/works/10.1007/S10549-010-1256-6

21 January 2018

Crosstalk between the insulin-like growth factors and estrogens in breast cancer.

1 reference

https://api.crossref.org/works/10.1007/S10549-010-1256-6

21 January 2018

Repeated observation of breast tumor subtypes in independent gene expression data sets

1 reference

https://api.crossref.org/works/10.1007/S10549-010-1256-6

21 January 2018

Expression of the insulin-like growth factor I receptor and urokinase plasminogen activator in breast cancer is associated with poor survival: potential for intervention with 17-allylamino geldanamycin

1 reference

https://api.crossref.org/works/10.1007/S10549-010-1256-6

21 January 2018

Expression of insulin-like growth factor 1 receptor in primary breast cancer: immunohistochemical analysis

1 reference

https://api.crossref.org/works/10.1007/S10549-010-1256-6

21 January 2018

Clinical and pathologic aspects of basal-like breast cancers

1 reference

https://api.crossref.org/works/10.1007/S10549-010-1256-6

21 January 2018

Gene expression profiling and histopathological characterization of triple-negative/basal-like breast carcinomas

1 reference

https://api.crossref.org/works/10.1007/S10549-010-1256-6

21 January 2018

Validation of tissue microarray technology in breast carcinoma

1 reference

https://api.crossref.org/works/10.1007/S10549-010-1256-6

21 January 2018

Tissue microarrays for high-throughput molecular profiling of tumor specimens

1 reference

https://api.crossref.org/works/10.1007/S10549-010-1256-6

21 January 2018

Estrogen utilization of IGF-1-R and EGF-R to signal in breast cancer cells

1 reference

https://api.crossref.org/works/10.1007/S10549-010-1256-6

21 January 2018

Molecular mechanisms involved in activity of h7C10, a humanized monoclonal antibody, to IGF-1 receptor.

1 reference

https://api.crossref.org/works/10.1007/S10549-010-1256-6

21 January 2018

Clinical significance of insulin-like growth factor-1 receptor expression in stage I non-small-cell lung cancer: immunohistochemical analysis

1 reference

https://api.crossref.org/works/10.1007/S10549-010-1256-6

21 January 2018

A heterozygous mutation of the insulin-like growth factor-I receptor causes retention of the nascent protein in the endoplasmic reticulum and results in intrauterine and postnatal growth retardation

1 reference

https://api.crossref.org/works/10.1007/S10549-010-1256-6

21 January 2018

SUMOylation mediates the nuclear translocation and signaling of the IGF-1 receptor

1 reference

https://api.crossref.org/works/10.1007/S10549-010-1256-6

21 January 2018

Type 1 insulin-like growth factor receptor translocates to the nucleus of human tumor cells

1 reference

https://api.crossref.org/works/10.1007/S10549-010-1256-6

21 January 2018

Inhibition of insulin-like growth factor-I receptor (IGF-IR) signaling and tumor cell growth by a fully human neutralizing anti-IGF-IR antibody

1 reference

https://api.crossref.org/works/10.1007/S10549-010-1256-6

21 January 2018

Insulin-like growth factor (IGF)-I, IGF binding protein-3, and cancer risk: systematic review and meta-regression analysis

1 reference

https://api.crossref.org/works/10.1007/S10549-010-1256-6

21 January 2018

IGF-I, IGF binding protein-3 and breast cancer risk: Comparison of 3 meta-analyses

1 reference

https://api.crossref.org/works/10.1007/S10549-010-1256-6

21 January 2018

Insulin-like growth factor 1 (IGF1), IGF binding protein 3 (IGFBP3), and breast cancer risk: pooled individual data analysis of 17 prospective studies

1 reference

https://api.crossref.org/works/10.1007/S10549-010-1256-6

21 January 2018

Induction of insulin-like growth factor binding protein expression by ICI 182,780 in a tamoxifen-resistant human breast cancer cell line

1 reference

https://api.crossref.org/works/10.1007/S10549-010-1256-6

21 January 2018

Altered expression of the IGF-1 receptor in a tamoxifen-resistant human breast cancer cell line

1 reference

https://api.crossref.org/works/10.1007/S10549-010-1256-6

21 January 2018

A new mutational AKTivation in the PI3K pathway

1 reference

https://api.crossref.org/works/10.1007/S10549-010-1256-6

21 January 2018

A functional genetic approach identifies the PI3K pathway as a major determinant of trastuzumab resistance in breast cancer

1 reference

https://api.crossref.org/works/10.1007/S10549-010-1256-6

21 January 2018

Insulin-like growth factor-I activates gene transcription programs strongly associated with poor breast cancer prognosis

1 reference

https://api.crossref.org/works/10.1007/S10549-010-1256-6

21 January 2018

Insulin receptor is an independent predictor of a favorable outcome in early stage breast cancer

1 reference

https://api.crossref.org/works/10.1007/S10549-010-1256-6

21 January 2018

Phosphorylated insulin-like growth factor-i/insulin receptor is present in all breast cancer subtypes and is related to poor survival.

1 reference

https://api.crossref.org/works/10.1007/S10549-010-1256-6

21 January 2018

Igf1r as a therapeutic target in a mouse model of basal-like breast cancer

1 reference

https://api.crossref.org/works/10.1007/S10549-010-1256-6

21 January 2018

Identifiers

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q51531354&oldid=2254994847"